Cerebral volume loss has long been associated with normal aging, but whether this is due to aging itself or to age-related diseases, including incipient Alzheimer disease, is uncertain. To understand the changes that occur in the aging brain, we examined the cerebral cortex of 27 normal individuals ranging in age from 56 to 103 years. None fulfilled the criteria for the neuropathologic diagnosis of Alzheimer disease or other neurodegenerative disease. Seventeen of the elderly participants had cognitive testing an average of 6.7 months prior to death. We used quantitative approaches to analyze cortical thickness, neuronal number, and density. Frontal and temporal neocortical regions had clear evidence of cortical thinning with age, but total neuronal numbers in frontal and temporal neocortical regions remained relatively constant during a 50-year age range. These data suggest that loss of neuronal and dendritic architecture, rather than loss of neurons, underlies neocortical volume loss with increasing age in the absence of Alzheimer disease.
INTRODUCTION
Cerebral volume loss has been observed in neuroradiologic studies as part of the spectrum of changes associated with normal aging, but whether this volume loss represents neuronal loss, incipient or asymptomatic neurodegenerative diseases, or other pathologic processes is not clear. Both longitudinal and cross-sectional imaging studies have examined volume loss in nondemented older individuals (1Y5). The whole-brain atrophy rate is Y0.45% per year in adulthood (2) . Volumetric magnetic resonance imaging studies have found that both cortical and white matter volume decrease with age; gray matter volume declined in a linear fashion from early adulthood, whereas white matter volume loss seemed to start later in life and did not follow a linear pattern (3) . Other studies have reported similar estimates of volume loss and decreases in hippocampal volume in older adults (1, 4, 6) . Some neuroimaging studies indicate that certain cortical regions, particularly the frontal lobes, are more vulnerable to volume loss with aging (4, 7Y9). The extent to which these neuroimaging studies are influenced by the presence of asymptomatic Alzheimer disease (AD)Ylike neuropathologic changes or other age-related pathologic processes such as vascular disease is uncertain. This is especially important because recent clinical-pathologic correlation studies highlight the surprisingly frequent occurrence of substantial AD-related neuropathologic changes (including atrophy) in cognitively intact elderly persons (10, 11 ). An alternative commonly cited hypothesis regarding brain changes with aging states that neuronal loss becomes prominent in the decades after middle age (12) . Several neuropathologic studies suggest, however, that the number of neurons in the cerebral cortex remains stable in the normal aging process (13Y15). For example, Pakkenberg and Gundersen (16) and Pakkenberg et al (17) reported the number of neurons lost from early adulthood to the age of 90 years to be less than 10% in a cohort the clinical status of which was unknown. The number of glial cells also did not show a significant change (17) . The effect of aging on neuronal number within the human hippocampus has also been examined. Reduction in the number of neurons within the CA1 sector of the hippocampus was found with the development of AD but did not occur in normal aging (18Y20), although some neuronal loss in subiculum and CA4 was noted.
To understand the effects of aging on the human cerebral cortex, we examined the cortex of 27 individuals ranging in age from 56 to 103 years, none of whom had the neuropathologic findings of AD or other neurodegenerative illness. Seventeen of these patients had had cognitive testing prior to their death. To examine the hypothesis that aging, even if not confounded by neurodegenerative disease, leads to structural changes in the brain, we analyzed changes within the cortical layering, overall thickness, neuronal number, and neuronal size distribution.
MATERIALS AND METHODS

Subjects
Twenty-seven subjects with no clinical or neuropathologic evidence of AD and who were part of the Alzheimer Disease Research Center at Massachusetts General Hospital from 1991 to 2006 were selected. Consent was given for brain donation by next-of-kin in all cases, and a postmortem examination was conducted by the Alzheimer Disease Research Center according to standardized protocols. The pathologic material and all available clinical history were reviewed on all cases. Seventeen of the subjects were elderly residents at Hebrew Rehabilitation Center, a long-term care facility in Boston, MA, and had agreed to annual cognitive testing and a brain autopsy. These cognitively tested subjects from the long-term care facility were considered eligible for inclusion if they had no or mild cognitive impairment based on chart review and interviews with nursing and medical staff conducted by a trained research nurse and geriatrician. Consortium to Establish a Registry for Alzheimer's Disease-based neuropsychological testing was performed on an annual basis on these 17 participants.
Tissue Collection and Diagnosis
At autopsy, coronal slices from 1 hemisphere were snapfrozen between dry iceYcooled aluminum plates; the opposite hemisphere was fixed in 10% buffered formalin. The fixed hemisphere was cut in the coronal plane, and blocks were selected from 17 to 19 brain areas for a comprehensive evaluation of the neurodegenerative process, as previously described (21) . The formalin-fixed blocks were exposed to 90% formic acid for 1 hour prior to dehydration and paraffin embedding. Eight-micrometer histologic sections were stained with Luxol fast blue-hematoxylin and eosin stain. Selected blocks were also evaluated with Bielschowsky silver impregnation, Congo red stain, or A-amyloid immunostain (Dako, Carpinteria, CA) and anti-NeuN (Chemicon, Temecula, CA) immunostain. Neuropathologic diagnoses were made according to established diagnostic criteria (22, 23) .
Microscopy and Quantitative Analysis
We applied stereologic approaches, emphasizing systematic random sampling of the microscope fields throughout multiple cortical regions, to assess neuronal number, density, and percent of cortex occupied by each cortical lamina using commercial image analysis/stereology packages.
Luxol fast blue-hematoxylin and eosin-stained sections from the superior frontal gyrus, temporal pole, and hippocampus were analyzed using unbiased stereologic counting methods to determine neuron density and number. Measurements of the full cortical thickness and separate measures of the molecular layer thickness were made over 20 points distributed over the entire cortical section. Areas without complete cortical layers were excluded. The mean full cortical thickness and mean thickness of the molecular layer were calculated for each case. An image analysis system (CAST; Olympus, Melville, NY) mounted on an upright BX51 Olympus microscope with an integrated motorized stage (Prior Scientific, Rockland, MA) was used to outline regions, sample, and count neurons. The neurons were counted manually in Luxol fast blue-hematoxylin and eosin-stained sections. Results of these counts were confirmed using anti-Neu-N immunostained sections of the frontal cortex for selected cases. A probe was then used with a meander sampling paradigm to sample an area of cortex at the crest of a gyrus in the sections. Approximately 100 points per case were sampled, and the cortical layer in which these points were distributed was recorded. This provided a percentage of the cortex making up each cortical layer. Each cortical layer was outlined, and a stereologic counting frame was used to determine neuronal density for each cortical layer. Neurons were counted in a 28.1 Â 28.1 Â 8-Km counting frame placed using a meander sampling paradigm with step lengths needed to sample 100 to 250 neurons per region. Typical step lengths were 125 Km in Layer I, 125 to 150 Km in Layer II, 200 Km in Layer III, 150 to 200 Km in Layer IV, and 175 to 250 Km in Layers V and VI. Layers V and VI were counted as a single region. Neuronal densities were calculated for each cortical layer and for the entire cortical thickness. Neuronal number was calculated from the estimated neuronal density and then standardized based on a 1-mm width of cortex and the previously measured average cortical thickness for each case.
Statistical Analysis
Pearson correlations, partial correlations, multiple regression, and analysis of covariance were used to test the relationships between the neuropathologic variables, age, sex, and Mini-Mental State Examination (MMSE) score. Confidence intervals (CIs) for regression coefficients were calculated with 95% confidence limits. Significance tests were 2-tailed, with > level set at 0.05. SAS version 9.1.3 statistical/graphical software was used to perform the analyses. 
RESULTS
Demographics
All patients were white and ranged in age from 56 to 103 years old; 16 were women, and 11 were men. Seventeen of the patients had had cognitive testing 0.5 to 16 months prior to death (mean, 6.7 months; Tables 1 and 2 ). Based on clinical judgment and chart review, none of the patients met the National Institute of Neurological Disorders and Stroke criteria for dementia.
Neuropathologic Evaluation
Most of the brains had evidence of cerebrovascular disease, and many had gross and microscopic infarcts. One patient had a recent hemorrhage. Most of the brains also contained neurofibrillary tangles, but no case scored higher 
Cortical Thinning Occurs With Increasing Age
The cortical thickness decreased by 0.8%/year with increasing age in the frontal cortex at a rate of Y25 Km/year (n = 27; r = Y0.75; p G 0.0001; 95% CI, Y35.09 to Y16.4 Km/ year). Within the temporal cortex, a trend of decreasing cortical thickness was evident with a 0.67% decrease/year at a rate of Y27 Km/year (n = 17; r = Y0.43; p = 0.085; 95% CI, Y59.4 to 4.32 Km/year; Figs. 1A, B) . The hippocampal CA1 region in 21 cases demonstrated similar volume loss of 0.8% and a rate of Y69,081 Km 2 /year, but the correlation of CA1 sector size with age did not reach statistical significance (n = 21; r = Y0.24; p = 0.2885; 95% CI, Y201487 to 63325 Km 2 /year; Fig. 1C ). An analysis of covariance of frontal and of temporal thickness, by sex and covarying age, showed volume loss, density, and number of neurons were not influenced by sex, nor did men and women differ in the slope of the linear relationship of thickness to age (Fig. 2) .
We next evaluated whether neuronal density changes with age. The neuronal density calculated for the entire cortical thickness (all layers) within the frontal and temporal cortex did not change with increasing age (mean, 83,155.13 neurons/mm 3 ; n = 27; r = 0. Fig. 3C ). Because the cortical thickness decreases with age and the neuronal density does not, we asked if the total number of neurons in a column of cortex diminished with age. To estimate the number of neurons in a 1-mm-wide full-thickness cortical strip, we multiplied the measured neuronal density by the average measured section cortical thickness. Thus, the neuronal number was calculated for a region of the same width but varied based on the average cortical thickness measurement for each case. The result indicated that the number of neurons stays constant with age for both frontal and temporal regions, that is, the loss of cortical volume seen with age is offset by the small increase in neuronal density (r for age vs number of neurons was virtually zero in each case; Fig. 4A, B) . On the other hand, the CA1 sector of the hippocampus had a decreased area with age ( Fig. 1C ) but no change in neuronal density (Fig. 3C) . The decline in CA1 neuron number with age did not, however, reach statistical significance (r = Y0.26; p = 0.25; Fig. 4C ).
We next examined whether the other neuropathologic findings observed were incidental or correlated with cognitive alteration as assessed by last known MMSE prior to death. Neuritic plaque burdens ranged from sparse to moderate, and the Braak and Braak score in all cases was III or less. In AD patients, there is extensive plaque and tangle burden with prominent cortical atrophy and neuronal loss. In our patients who did not have AD, neuritic plaques (a rank ordinal scale of density) and tangle burden (the Braak and Braak stage) were positively correlated with age (r = 0.55, p G 0.003 vs plaques and r = 0.75, p G 0.0001 vs Braak and Braak). Thus, it was important to assess the relations of age, plaque burden, and Braak and Braak score to the other brain measures, where the former are statistically adjusted for (i.e. partialed from) each other via multiple regression to estimate nonspurious, unconfounded relations for each. Partialed relations of age versus thickness were found to be negative but stronger and more significant than in the case of the ordinary unadjusted Pearson correlations previously reported (frontal: partial r = Y0.60, p = 0.0014; temporal: partial r = Y0.63, p = 0.0125; hippocampus: partial r = Y0.38, p = 0.1). Across all the 3 brain regions, however, the partialed relations of plaques and tangles to cortical thickness were not significant (except for a positive relation for Braak score in the temporal lobe, partial r = 0.6, p = 0.02). Thus, age seems to have a true negative relation to cortical thickness, which becomes stronger when the obscuring, confounding effects of plaques and tangles are statistically held constant. This also suggests that there was no direct influence of the small numbers of plaques and tangles on the decrease in cortical thickness and, therefore, that the cortical changes seen in aging are not simply the result of early AD changes but are related to aging itself. The presence of diffuse plaques, vascular lesions (i.e. atherosclerosis or microinfarcts), or Lewy bodies in the substantia nigra did not correlate with cortical atrophy. Cortical atrophy also did not correlate with MMSE score (Fig. 5A, B) .
DISCUSSION
Volumetric imaging studies of the human brain have demonstrated volume loss of both the cortex and white matter with aging (2Y4, 6). Our results indicate that the cortex becomes thinner with age corresponding to these volumetric studies and suggest that the observed neuropathologic changes reflect this same pathologic process. With aging, there are also functional changes in the brain that are not necessarily associated with AD (24) and may indicate that some regions are differentially affected. The frontal cortex is 1 area that consistently shows volume loss with age (7, 8, 25) and functional alterations (26) .
Through stereologic methods, our results indicate that while the frontal and temporal regions of cortex are undergoing thinning, the total neuronal number remains relatively constant during the 47-year age range (i.e. from 56 to 103 years). The absence of neuronal loss with increasing age is comparable and consistent with data from Pakkenberg et al (17) for whole-brain neuron counts and for previous studies of entorhinal cortex (15) and superior temporal sulcus (27) . What accounts for the cortical thinning? The cerebral cortex is composed of a set number of elements, including neurons, glia, microglia, neuropil, and blood vessels. If neurons are not lost, one is left to question what is leading to the clear decrease in cortical volume. Previous studies have suggested an age-related decrease in neuronal size (13) and loss of presynaptic terminals (28) . Loss of complexity of dendritic arborizations has also been described in Golgi studies of Bnormal[ aging (29) . Although the present study did not examine the white matter in these cases, the reported observation of volume loss in this compartment also suggests that some of the decrease in cortical thickness could be attributed to loss of ascending projections to the cortex. Together, these data suggest that loss of neuropil (i.e. neuronal structural complexity) might contribute to the dramatic thinning that occurs with increasing age.
The aging process has also been examined in the nonhuman primate neocortex. Although some structural changes, including thinning of Layer I, reduction of synapses, and changes in strength of microcolumns, have been identified, the cortical neuronal numbers seemed to stay constant with age (14, 30Y33). Therefore, in nonhuman primates, agerelated changes also seem to involve cortical thinning and remodeling of Layer I and neuropil rather than neuronal loss per se. Defining the cortical changes may contribute to understanding the cognitive alterations associated with aging and help distinguish this process from age-related neurodegenerative diseases.
Many of the elderly subjects in this study had evidence of vascular disease and infarcts, but even in these patients, neuronal loss was not present, and the decrease in cortical volume still correlated with age. The vascular disease observed indicates the importance of understanding its effects on changes in cognition and white matter volume loss in aging.
The sample size in this study was limited, particularly in the temporal and hippocampal regions. A power analysis indicated that with n = 27, we had good power (È0.8) to detect a population correlation of r = 0.5 or higher. Smaller effects may have escaped detection (34) . Therefore, negative results must be interpreted with caution, pointing to the need for further study in a large sample to clarify these issues.
Volume loss was also demonstrated in the CA1 sector of the hippocampus, a finding that has been seen in nondemented aged individuals by magnetic resonance imaging examination (35) . The neuronal density in this region remained constant with age, and the actual number of neurons were decreased, but not to a significant extent. This observation is in agreement with prior stereologic studies of the CA1 sector, which found that the neuronal number stayed constant with age and in patients with mild cognitive impairment (19, 20) . It should be noted, however, that our definition of the CA1 region was more restricted than that described by West and Gundersen (18) , and many of the individuals in our study had other age-related systemic diseases, including hypertension, cerebral atherosclerosis, microinfarcts, lacunes, white matter pallor, and hippocampal sclerosis (1 case was excluded from analysis).
All of the cognitively tested patients in the present study were not demented from a neuropsychological perspective when they were initially tested several years prior to their deaths. However, several individuals developed decrements in the MMSE and impairments in verbal delayed recall within the year prior to death. None of these patients had neuropathologic features of AD at autopsy. These individuals did not have more severe changes in the neuropil than other similarly aged individuals, and we attribute their mild impairments to vascular lesions in the setting of age-related diminished Breserve[ due to loss of neuropil integrity (Table 2) . Interestingly, we did not identify any specific factor, including diffuse amyloid deposits, Lewy bodies in the substantia nigra, or atherosclerosis, as contributing to the decline in MMSE. Indeed, what is striking is that cognition is relatively well preserved in these elderly individuals despite a loss of cortical neuropil that is sufficient to cause readily detectable changes in cortical volume. Thus, age-related brain atrophy, well documented in numerous neuroimaging studies, likely reflects atrophy of dendritic fields in neuropil rather than loss of neurons. This is consistent with the hypothesis that there is little or no cortical neuronal loss simply as a consequence of aging.
In summary, we have examined the brains of a cohort of nondemented individuals aged 56 to 103 years who, by clinical and neuropathologic evaluation, were free of AD and other age-related neurodegeneration for age-related brain changes that may be attributable to non-AD causes, including aging per se. We confirmed neuroradiologic observations of cortical shrinkage and found rates of Y0.8%/year in the frontal cortex and Y0.67%/year in the temporal cortex. In contrast to classical observations, we did not detect evidence for neuronal loss even in extreme old age. Our results also support the neuroimaging data of greater volume loss within the frontal cortex over temporal cortex in aging. We suggest that there may be changes in either neuronal size or a simplification in the complexity of dendritic and axonal interactions in the neuropil (as suggested by earlier Golgi staining evaluation of the aging cortex) (29) . We speculate that this change in cortical structure, rather than neuronal loss, provides the substrate for age-related volume loss and age-related cognitive changes and dramatically differentiates the effects of aging from those of AD in which both neuronal number and neuronal density are diminished.
